HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pert "Separates" Hair Care Ads Promote Individual Shampoo/Conditioners

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble's Pert "separates" hair care advertising campaign stars Pert spokesperson "Sinkguy" and sets of real-life twins to demonstrate the brand's new line of individual shampoos and conditioners.

You may also be interested in...



P&G Aiming To Perk Up Pert, Renew Renewal 5x With Repositioning

Procter & Gamble is phasing out its Pert "separates" in favor of a return to the brand's original 2-in-1 shampoo and conditioner products, P&G said. The change is meant to "return Pert Plus to its strong brand identity" as "the 2-in-1 shampoo that leaves your hair lighter and livelier," according to the firm

P&G Aiming To Perk Up Pert, Renew Renewal 5x With Repositioning

Procter & Gamble is phasing out its Pert "separates" in favor of a return to the brand's original 2-in-1 shampoo and conditioner products, P&G said. The change is meant to "return Pert Plus to its strong brand identity" as "the 2-in-1 shampoo that leaves your hair lighter and livelier," according to the firm

P&G Beauty Head Lafley Named CEO, Pepper Reinstated As Chairman

Procter & Gamble CEO-elect A.G. Lafley will use his past experience in revitalizing P&G's hair care business to recharge the consolidated company and forge a more carefully paced strategic direction. Lafley succeeds Durk Jager, who will retire July 1.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel